Stay updated on Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Sign up to get notified when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.

Latest updates to the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page
- Check3 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center status, with links for updated operating information (cc.nih.gov and opm.gov). Updated the page revision tag from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check10 days agoChange DetectedAdded a glossary toggle and minor UI/label/version text updates (including capitalization and QC-related fields); these do not alter study data, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now shows Revision: v3.3.4 and no longer lists Revision: v3.3.3.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page now includes a Locations section listing the study sites by state (Alabama, California, Florida, Georgia, Minnesota, Missouri, North Carolina, Texas).SummaryDifference0.8%

- Check75 days agoChange DetectedPublications section now states that publications are automatically filled from PubMed and may not be about the study. The revision/version information has been updated to v3.3.2 (from v3.2.0).SummaryDifference0.1%

- Check82 days agoChange DetectedRemoved the government funding lapse notice banner from the page; this administrative update does not affect the study details or user actions — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapid Test & Treat Dolutegravir Plus Lamivudine Clinical Trial page.